Canada markets closed

Hemostemix Inc. (HEM.V)

TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
0.25500.0000 (0.00%)
At close: 11:26AM EDT
Full screen
Previous Close0.2550
Open0.2500
Bid0.2500 x 0
Ask0.2900 x 0
Day's Range0.2500 - 0.2550
52 Week Range0.1300 - 0.4200
Volume21,300
Avg. Volume110,714
Market Cap17.404M
Beta (5Y Monthly)0.15
PE Ratio (TTM)N/A
EPS (TTM)-0.1230
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Newsfile

    Hemostemix Announces Closing of UNIT Private Placement

    Calgary, Alberta--(Newsfile Corp. - June 22, 2022) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) ("Hemostemix" or the "Company") is pleased to announce it closed the first tranche of its non-brokered private placement of units ("Units") announced on May 19, 2022, for gross proceeds of $690,388.80 (the "Offering"). The Offering consisted of the issuance of an aggregate of 2,301,296 Units at a price of $0.30 per Unit. Each Unit consists of one common ...

  • Newsfile

    Hemostemix Announces the Incorporation of PreCerv Inc. And a Global Field of Use License to NCP-01

    Calgary, Alberta--(Newsfile Corp. - June 14, 2022) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) ("Hemostemix" or the "Company") is pleased to announce it has incorporated PreCerv Inc. ("PreCerv"), as a wholly owned subsidiary. PreCerv will obtain from Hemostemix a global field of use license to NCP-01 and its autologous stem cell technologies, to treat conditions of the central and peripheral nervous system, including but not limited to the following:Neuropathic pain syndromes.Traumatic spinal c

  • Newsfile

    Hemostemix Announces Financing

    Calgary, Alberta--(Newsfile Corp. - May 19, 2022) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) ("Hemostemix" or the "Company") is pleased to announce a non-brokered private placement of up to 15 Million Units priced in the context of the market. Each Unit consists of one common share in the capital of the Company ("Common Share") and one common share purchase warrant ("Warrant"), with each full Warrant entitling the holder to acquire one Common ...